LL-37
A host-defense research peptide (LL-37) coming soon to the Atlas catalog — of interest in antimicrobial and immune-signaling research. Planned in 10 mg lyophilized vials.
Planned sizes
Not yet available — pricing and availability to be announced.
- A cathelicidin-family host-defense peptide of interest in antimicrobial research.*
- Explored in immune-signaling and wound-research models.*
- Planned in 10 mg lyophilized vials.*
For research use only. Not for human or animal consumption.
Why researchers choose it
The LL-37 difference
What sets it apart — framed for research context.
- 01
A cathelicidin-family host-defense peptide of interest in antimicrobial research.*
- 02
Explored in immune-signaling and wound-research models.*
- 03
Planned in 10 mg lyophilized vials.*
More from this line
Important information
These statements have not been evaluated by the Food and Drug Administration. This product is intended for research use only and is not intended to diagnose, treat, cure, or prevent any disease, nor for human or animal consumption.
- *LL-37 is not yet available. Research-context statements are placeholders pending Arix's review and are not medical claims.
Claim wording is placeholder — pending Arix approval.